These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 23303697)
1. Molecular mechanisms of curcumin action: signal transduction. Shehzad A; Lee YS Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697 [TBL] [Abstract][Full Text] [Related]
2. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156 [TBL] [Abstract][Full Text] [Related]
3. Chemopreventive and therapeutic effects of curcumin. Duvoix A; Blasius R; Delhalle S; Schnekenburger M; Morceau F; Henry E; Dicato M; Diederich M Cancer Lett; 2005 Jun; 223(2):181-90. PubMed ID: 15896452 [TBL] [Abstract][Full Text] [Related]
4. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Shehzad A; Wahid F; Lee YS Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007 [TBL] [Abstract][Full Text] [Related]
5. Cell signaling pathways altered by natural chemopreventive agents. Sarkar FH; Li Y Mutat Res; 2004 Nov; 555(1-2):53-64. PubMed ID: 15476851 [TBL] [Abstract][Full Text] [Related]
6. Plant-derived anticancer agents - curcumin in cancer prevention and treatment. Creţu E; Trifan A; Vasincu A; Miron A Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1223-9. PubMed ID: 23700916 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382 [TBL] [Abstract][Full Text] [Related]
8. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression. Chen J; Wang FL; Chen WD Mol Biol Rep; 2014 Jul; 41(7):4583-94. PubMed ID: 24604727 [TBL] [Abstract][Full Text] [Related]
9. Curcumin for chemoprevention of colon cancer. Johnson JJ; Mukhtar H Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598 [TBL] [Abstract][Full Text] [Related]
10. [Molecular and cellular mechanisms of curcumin action--beneficial effect on organism]. Sikora-Polaczek M; Bielak-Zmijewska A; Sikora E Postepy Biochem; 2011; 57(1):74-84. PubMed ID: 21735822 [TBL] [Abstract][Full Text] [Related]
11. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma. Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives. Kumar G; Mittal S; Sak K; Tuli HS Life Sci; 2016 Mar; 148():313-28. PubMed ID: 26876915 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of curcumin action: gene expression. Shishodia S Biofactors; 2013; 39(1):37-55. PubMed ID: 22996381 [TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823 [TBL] [Abstract][Full Text] [Related]
15. Curcumin in various cancers. Shehzad A; Lee J; Lee YS Biofactors; 2013; 39(1):56-68. PubMed ID: 23303705 [TBL] [Abstract][Full Text] [Related]
16. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. Liao S; Xia J; Chen Z; Zhang S; Ahmad A; Miele L; Sarkar FH; Wang Z J Cell Biochem; 2011 Apr; 112(4):1055-65. PubMed ID: 21308734 [TBL] [Abstract][Full Text] [Related]
18. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Sreekanth CN; Bava SV; Sreekumar E; Anto RJ Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920 [TBL] [Abstract][Full Text] [Related]
19. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Shankar S; Srivastava RK Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930 [TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]